Year archive

PolyPeptide Group AG — 2024 filings

All 20 regulatory filings released by PolyPeptide Group AG (PPGN) in 2024, sourced directly from the official regulator.

20 Filings

2024 Period

2024 filings (20)

Filing	Released	Lang
Large-scale SPPS capacity in Braine-lAlleud starts production Regulatory Filings	2024-12-17	English
Large-scale SPPS capacity in Braine-lAlleud starts production Regulatory Filings	2024-12-16	English
Large-scale SPPS capacity in Braine-l’Alleud starts production Regulatory Filings	2024-12-16	English
Grossvolumige SPPS-Kapazität in Braine-l’Alleud startet Produktion Regulatory Filings	2024-12-16	German
Solid progress in H1 2024 Upgrade of 2024 full-year guidance Mid-term target to double 2023 revenue by 2028 Earnings Release H1 2024	2024-08-13	English
Solid progress in H1 2024 – Upgrade of 2024 full-year guidance – Mid-term target to double 2023 revenue by 2028 Earnings Release H1 2024	2024-08-13	English
Solider Fortschritt im H1 2024 – Erhöhung der Prognose für das Gesamtjahr 2024 – Mittelfristiges Ziel, den Umsatz von 2023 bis 2028 zu verdoppeln Earnings Release H1 2024	2024-08-13	German
PolyPeptide appoints Chief Commercial Officer Board/Management Information	2024-08-08	English
PolyPeptide appoints Chief Commercial Officer Board/Management Information	2024-08-08	English
PolyPeptide ernennt Chief Commercial Officer Board/Management Information	2024-08-08	German
PolyPeptide announces results of the annual General Meeting 2024 AGM Information	2024-04-10	English
PolyPeptide announces results of the annual General Meeting 2024 AGM Information	2024-04-10	English
PolyPeptide gibt Ergebnisse der ordentlichen Generalversammlung 2024 bekannt AGM Information	2024-04-10	German
PolyPeptide publishes invitation to the annual General Meeting 2024 AGM Information	2024-03-19	English
PolyPeptide publishes invitation to the annual General Meeting 2024 AGM Information	2024-03-19	English
PolyPeptide publiziert Einladung zur ordentlichen Generalversammlung 2024 AGM Information	2024-03-19	German
PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow Earnings Release FY 2023	2024-03-12	English
PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow Earnings Release FY 2023	2024-03-12	English
PolyPeptide meldet Rekordumsatzwachstum von 43% in H2 2023 gegenüber H1 2023; operative Verbesserungen führen zu steigender Profitabilität und Cashflow Earnings Release FY 2023	2024-03-12	German
Annual Report 2023 Annual Report FY 2023	2024-03-08	English